A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
四位分析师一窥专家对Enfusion的展望
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Enfusion (NYSE:ENFN) in the last three months.
在过去三个月中，有4位分析师公布了对Enfusion（纽约证券交易所代码：ENFN）的评级，提供了从看涨到看跌的不同视角。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Enfusion, presenting an average target of $9.0, a high estimate of $10.00, and a low estimate of $8.00. A decline of 2.7% from the prior average price target is evident in the current average.
在对12个月目标股价的评估中，分析师公布了对Enfusion的见解，将平均目标价定为9.0美元，最高估计为10.00美元，低估值为8.00美元。目前的平均价格比先前的平均目标股价下降了2.7％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析师评级：深度分析
A comprehensive examination of how...
对金融专家...
登录免费看全文
登录/注册